Revivogen Reduces DHT by 90%, Beats Finasteride and Dutasteride in Study

LOS ANGELES , CA -- January 23, 2008 -- Can an all natural treatment for hairloss be more effective at reducing DHT than FDA approved treatments for hairloss? A new study sponsored by Advanced Skin and Hair Inc shows a greater inhibition of DHT in reconstructed human epidermis via Revivogen (90%) compared to Dutasteride (the medicine in Avodart, 86%) and Finasteride (67%). The study also showed that Revivogen reduced other metabolites of Testosterone.

The testing was performed by BIOalternatives. BIOalternatives is a service company offering cell-based assays to support drug and healthcare product development and provides customized informative biological solutions to over 200 companies through 16 countries all over the world.

Full study results